Mrv0541 08291310072D 20 21 0 0 0 0 999 V2000 6.9263 -17.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9263 -18.6206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.2118 -17.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2118 -19.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4973 -17.7957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4973 -18.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6407 -17.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.3550 -17.7957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.6407 -16.5583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.0695 -17.3831 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 9.7839 -17.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0695 -16.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7839 -16.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7839 -15.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4983 -16.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4984 -14.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2128 -16.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2128 -15.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7839 -18.6206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.4983 -17.3831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 2 0 0 0 0 4 2 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 6 5 2 0 0 0 0 1 7 1 0 0 0 0 7 8 1 0 0 0 0 7 9 2 0 0 0 0 10 8 1 1 0 0 0 10 11 1 0 0 0 0 10 12 1 0 0 0 0 14 13 1 0 0 0 0 15 13 2 0 0 0 0 16 14 2 0 0 0 0 17 15 1 0 0 0 0 18 16 1 0 0 0 0 18 17 2 0 0 0 0 12 13 1 0 0 0 0 11 19 2 0 0 0 0 11 20 1 0 0 0 0 M END > DBMET01064 > drugbank > OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1 > InChI=1S/C14H13N3O3/c18-13(12-9-15-6-7-16-12)17-11(14(19)20)8-10-4-2-1-3-5-10/h1-7,9,11H,8H2,(H,17,18)(H,19,20)/t11-/m0/s1 > DWYZPDHMMZGQAP-NSHDSACASA-N > C14H13N3O3 > 271.2713 > 271.095691297 > 5 > 33 > -0.9998376111182643 > 26.129442308552143 > 1 > 2 > 0 > 1 > (2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanoic acid > 0.26 > 0.7011415659999997 > -3.10 > 0 > -1 > 2 > -1 > 13.699142894599674 > 3.210790270366959 > -0.5868213111577959 > 92.18 > 70.54480000000001 > 5 > 1 > 2.15e-01 g/l > tetrahydrofolic acid > 0 > DBMET01064 > Bortezomib metabolite M4 > 9R67B83S2T $$$$